Cargando…

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

BACKGROUND: Thymidine kinase 1 (TK1) is an intracellular protein associated with DNA synthesis, expressed during the G1 phase and remained elevated through the M phase, with a potential as a biomarker for cell proliferation. In this study, we explore the possible use of TK1 in Hodgkin lymphoma (HL)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattsson Ulfstedt, Johan, Venge, Per, Holmgren, Sofia, Enblad, Gunilla, Eriksson, Staffan, Molin, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Academia 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383933/ https://www.ncbi.nlm.nih.gov/pubmed/34471484 http://dx.doi.org/10.48101/ujms.v126.6119

Ejemplares similares

P045: Plasma proteome profiling of cardiotoxicity in patients with Hodgkin lymphoma
por: Ulfstedt, Johan Mattsson, et al.
Publicado: (2022)

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue
por: Gholiha, Alex Reza, et al.
Publicado: (2021)

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
por: Hollander, Peter, et al.
Publicado: (2018)

Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma
por: Wang, Liya, et al.
Publicado: (2021)

Checkpoint CD47 expression in classical Hodgkin lymphoma
por: Gholiha, Alex Reza, et al.
Publicado: (2022)

P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin’ s lymphoma.
por: Linderoth, Johan, et al.
Publicado: (2022)

T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
por: Övergaard, Ninja, et al.
Publicado: (2022)

High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma – is there a need for intervention in long-term survivors?
por: Andersson, Anne, et al.
Publicado: (2021)

Quaternary structures of recombinant, cellular, and serum forms of Thymidine Kinase 1 from dogs and humans
por: Hanan, Sharif, et al.
Publicado: (2012)

Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
por: Lundgren, Per‐Olof, et al.
Publicado: (2022)

Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1
por: Wang, Naining, et al.
Publicado: (2001)

P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients
por: Goldkuhl, Christina, et al.
Publicado: (2022)

Negative Cooperative Binding of Thymidine, Ordered Substrate Binding, and Product Release of Human Mitochondrial Thymidine Kinase 2 Explain Its Complex Kinetic Properties and Physiological Functions
por: Wang, Liya, et al.
Publicado: (2018)

Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker
por: Wang, Liya, et al.
Publicado: (2021)

Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples
por: Jagarlamudi, K. K., et al.
Publicado: (2022)

Hodgkin lymphoma – a survey of children and adolescents treated in Sweden 1985–2009
por: Englund, Annika, et al.
Publicado: (2015)

Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non‐Hodgkin lymphoma
por: Boyé, Pierre, et al.
Publicado: (2019)

A monoclonal antibody-based sandwich ELISA for measuring canine Thymidine kinase 1 protein and its role as biomarker in canine lymphoma
por: Sharif, Hanan, et al.
Publicado: (2023)

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
por: Lagerlöf, Ingemar, et al.
Publicado: (2022)

Thymidine Kinase(+/−) Mammalian Cell Mutagenicity Assays for Assessment of Nanomaterials
por: Chen, Tao, et al.
Publicado: (2022)

Serum thymidine kinase in acute leukaemia.
por: Hagberg, H., et al.
Publicado: (1984)

THYMIDINE TRIPHOSPHATE SYNTHESIS IN TETRAHYMENA : I. Studies on Thymidine Kinase
por: Shoup, G. D., et al.
Publicado: (1966)

INDUCIBILITY OF THYMIDINE KINASE BY THYMIDINE AS A FUNCTION OF INTERPHASE STAGE
por: Hotta, Yasuo, et al.
Publicado: (1965)

Thymidine kinase in breast cancer.
por: Robertson, J. F., et al.
Publicado: (1990)

Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
por: Mörth, Charlott, et al.
Publicado: (2018)

Clinical performance of a commercially available thymidine kinase 1 assay for diagnosis of lymphoma in 42 hospitalized horses (2017‐2020)
por: Moore, Caitlin, et al.
Publicado: (2021)

Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2015)

Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2014)

A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2015)

Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.
por: Costa, A., et al.
Publicado: (1992)

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
por: Mörth, Charlott, et al.
Publicado: (2021)

Quantitative Cytology and Cytochemistry of Hodgkin's Tissue Labelled in vivo with Tritiated Thymidine
por: Peckham, M. J.
Publicado: (1973)

Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer
por: CHEN, FEIYU, et al.
Publicado: (2013)

3'-Amino thymidine affinity matrix for the purification of herpes simplex virus thymidine kinase.
por: Tung, P. P., et al.
Publicado: (1996)

Thymidine Kinase Type 1 and C‐Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer
por: Selting, K.A., et al.
Publicado: (2016)

Comparison of plasma and tissue thymidine kinase activities.
por: Calvert, R. J., et al.
Publicado: (1989)

Quaternary structure of vaccinia virus thymidine kinase
por: Black, Margaret E., et al.
Publicado: (1990)

ACQUISITION OF CHICK CYTOSOL THYMIDINE KINASE ACTIVITY BY THYMIDINE KINASE-DEFICIENT MOUSE FIBROBLAST CELLS AFTER FUSION WITH CHICK ERYTHROCYTES
por: Kit, Saul, et al.
Publicado: (1974)

Enhancing the sensitivity of the thymidine kinase assay by using DNA repair‐deficient human TK6 cells
por: Ibrahim, Mahmoud Abdelghany, et al.
Publicado: (2020)

Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.
por: Rehn, S., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_t0hgol9m5kp33hgc1i8ctj1rl7